Effectiveness of Mindfulness Based Cognitive Therapy in adults with high-functioning autism

Completed

• Conditions: autism; autism spectrum disorder; 10012562

• Registration Number: NL-OMON32624
• Lead Sponsor: GGZ Eindhoven (Eindhoven)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

Treatment groups meet DSM-IV/TR and ADI-R criteria for autistic disorder or Asperger disorder. Age 18-60. WAIS-III IQ score >85. Suffer from depressive complaints and/or sensory over-excitability
Control group: matched on gender and age.

Exclusion Criteria

Treatment group: no comorbid neuropsychiatric disorders such as substance abuse, epilepsy, neuropathologies
Control group: no known neuropsychiatric disorders such as depression, addiction, epilepsy, neuropathology; use of psycho-active medication.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Depressive complaints: SCL-90 scores<br /><br>Sensory processing:AASP scores<br /><br>mindfulness skills: FFMQ scores<br /><br>interpersonal functioning and functioning in society : OQ-45 scores<br /><br>neurometric measures:<br /><br>* quantitative EEG (qEEG); spectral parameters; coherence measures<br /><br>* Event Related Potentials measures: latency/amplitude N2/P3 components<br /><br>* neuropsychological measures (reaction times, error rates etc.)<br /><br>* autonomous nervous system measures (heart rate variability, electrodermal<br /><br>activity) </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>N/A</p><br>